作为慢性阻塞性肺病长期死亡风险因素的低寿命基本8分:基于对2007年至2012年NHANES数据分析的研究
Chang Sun1, Xin Xin Zhang2, Jie Cao1
1Department of Respiratory and Critical Care, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
International journal of chronic obstructive pulmonary disease
|December 3, 2024
概括
使用Life Essential 8 (LE8) 改善心血管健康与慢性阻塞性肺病 (COPD) 患者的死亡风险降低有关. 在这个群体中,较高的LE8得分与减少全因,CLRD和癌症死亡率相关.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 公共卫生 公共卫生
背景情况:
- 心血管健康 (CVH) 对于整体健康至关重要.
- 美国心脏协会 (AHA) 更新了其对CVH评估的算法,将其更新为Life Essential 8 (LE8).
- 慢性阻塞性肺部疾病 (COPD) 患者面临高死亡风险,通常由心血管问题加剧.
研究的目的:
- 调查慢性阻塞性肺病 (COPD) 患者更新的生命必需品8 (LE8) 评分和死亡风险之间的关联.
- 为了确定心血管健康的改善,以LE8测量,是否会影响COPD全因和因特定死亡率.
主要方法:
- 一项前性队列研究,利用2007-2012年国家健康和营养检查调查 (NHANES) 和国家死亡指数的数据.
- 用有限立方线的考克斯比例危险模型来分析LE8得分与死亡率之间的关系.
- 分析包括785名受试者,死亡率数据截至2019年12月31日.
主要成果:
- 在总人口中,LE8得分增加10个点与心血管疾病 (CVD) 死亡率降低4%的风险有关.
- 在COPD患者中,较高的LE8得分与所有原因死亡率 (4%),CLRD死亡率 (8%) 和癌症死亡率 (12%) 的风险相对较低.
- 与低CVH相比,中度和高CVH (基于LE8) 与分别降低23%和40%的死亡风险有关.
结论:
- 低水平的生命必需品8 (LE8) 与COPD患者全因和因特定死亡率的增加显著相关.
- 维护和改善心血管健康,根据LE8的量化,可能是减少COPD患者死亡率的关键策略.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
178
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
178
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


